Gerald Cysewski - Cyanotech Director

CYANDelisted Stock  USD 0.88  0.05  6.02%   

Director

Dr. Gerald R. Cysewski, Ph.D. is President, Vice Chairman of the Board, Chief Scientific Officer of the Company. He was became President and Chief Executive Officer as of August 25, 2016, after having served as Interim President and Chief Executive Office beginning March 31, 2016. Prior to this he was Executive Vice President and Chief Scientific Officer. Dr. Cysewski cofounded the Company in 1983 and has served as a director of the Company since that time. From 1990 to May 16, 2008, Dr. Cysewski served as the Companys President and Chief Executive Officer, as well as Chairman of the Board. Prior to 1990, Dr. Cysewski served in various other capacities for the Company including Vice Chairman and Scientific Director. From 1980 to 1982, Dr. Cysewski was Group Leader of Microalgae Research and Development at Battelle Northwest, a major contract research and development firm. From 1976 to 1980, Dr. Cysewski was an assistant professor in the Department of Chemical and Nuclear Engineering at the University of California, Santa Barbara, where he received a twoyear grant from the National Science Foundation to develop a culture system for bluegreen algae. Dr. Cysewski received his doctorate in Chemical Engineering from the University of California at Berkeley. Dr. Cysewski continues to be recognized as a leading authority on large scale production of microalgae and is a frequently invited speaker at industry gatherings around the world, providing insight to the Board on changes in microalgae science and regulatory matters that impact the Company. His extensive experience with the Company and his expertise in microalgae production make him uniquely qualified to serve on our Board. since 2019.
Age 75
Tenure 5 years
Professional MarksPh.D
Phone808 326 1353
Webhttps://www.cyanotech.com
Cysewski received his doctorate in Chemical Engineering from the University of California at Berkeley.

Cyanotech Management Efficiency

The company has return on total asset (ROA) of (0.0851) % which means that it has lost $0.0851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2925) %, meaning that it created substantial loss on money invested by shareholders. Cyanotech's management efficiency ratios could be used to measure how well Cyanotech manages its routine affairs as well as how well it operates its assets and liabilities.
Cyanotech currently holds 11.17 M in liabilities with Debt to Equity (D/E) ratio of 0.44, which is about average as compared to similar companies. Cyanotech has a current ratio of 3.62, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cyanotech's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

DIRECTOR Age

John HansonCentral Garden Pet
58
Mary SpringerCentral Garden Pet
60
Travis RobbinsBridgford Foods
N/A
Raymond LancyBridgford Foods
70
John BasonAssociated British Foods
66
Mary SpringerCentral Garden Pet
60
John HansonCentral Garden Pet
58
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii. Cyanotech Corp operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. Cyanotech (CYAN) is traded on NASDAQ Exchange in USA. It is located in 73-4460 Queen Kaahumanu Highway, Kailua-Kona, HI, United States, 96740 and employs 86 people. Cyanotech is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Cyanotech Leadership Team

Elected by the shareholders, the Cyanotech's board of directors comprises two types of representatives: Cyanotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cyanotech. The board's role is to monitor Cyanotech's management team and ensure that shareholders' interests are well served. Cyanotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cyanotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Amy Nordin, VP Secretary
Charles Hartmann, Vice Marketing
Matthew Custer, CEO President
Felicia Ladin, CFO Treasurer
Glenn Jensen, VP of Operations
Collette Kakuk, Chief Officer
Gerald Cysewski, Co-Founder, Chief Scientific Officer, Executive VP and Executive Director

Cyanotech Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cyanotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Cyanotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyanotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyanotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Cyanotech Stock

  0.8FRPT Freshpet Potential GrowthPairCorr
  0.68HLF Herbalife NutritionPairCorr
  0.62PPC Pilgrims Pride CorpPairCorr
  0.53DAR Darling IngredientsPairCorr
  0.51CENTA Central Garden PetPairCorr
The ability to find closely correlated positions to Cyanotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyanotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyanotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyanotech to buy it.
The correlation of Cyanotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyanotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyanotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyanotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Cyanotech Stock

If you are still planning to invest in Cyanotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyanotech's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets